Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1025 | 1043 | 1052 | 1283 | 1505 | 1932 |
Fund Return | 2.51% | 4.29% | 5.18% | 8.67% | 8.53% | 6.81% |
Place in category | 285 | 47 | 517 | 243 | 197 | 121 |
% in Category | 46 | 6 | 87 | 44 | 44 | 62 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Foord Balanced Fund C | 25.3B | 6.51 | 5.28 | 8.41 | ||
Foord Balanced Fund B4 | 24.95B | 11.26 | 9.53 | 6.98 | ||
Foord Balanced Fund B1 | 24.95B | 1.12 | 9.04 | 7.14 | ||
Foord Balanced Fund B3 | 24.95B | 1.10 | 9.23 | 7.42 | ||
Foord Balanced Fund B | 24.95B | 1.22 | 9.79 | 8.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allan Gray Balanced Fund A | 190.1B | 2.01 | 10.94 | 8.19 | ||
Allan Gray Balanced Fund C | 190.1B | -0.07 | 11.22 | 8.48 | ||
Allan Gray Balanced Fund X | 190.1B | 12.10 | 14.88 | - | ||
Coronation Balanced Plus Fund P | 114.49B | 3.10 | 9.48 | 8.42 | ||
Coronation Balanced Plus Fund D | 114.49B | 3.12 | 8.69 | 8.15 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Foord SICAV Foord International Fund B | LU0914416242 | 18.20 | 50.506 | +0.30% | |
Foord Global Equity Class X | SGXZ22939185 | 13.33 | - | - | |
Prosus | NL0013654783 | 6.33 | 35.78 | -2.29% | |
Foord Global Equity (Lux) X Cap | LU0914416838 | 5.80 | - | - | |
Aspen Pharmacare Holdings | ZAE000066692 | 4.71 | 22,979 | -0.84% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review